Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer

By            

Oncology Letters, Vol. 5, Iss. 6, 2013-01 ,pp. : 1943-1947

Spandidos Publications

Access to resources Recommend Favorite

Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer

By Yamamoto Taketsugu   Oshima Takashi   Yoshihara Kazue   Nishi Teppei   Arai Hiromasa   Inui Kenji   Kaneko Takeshi   Nozawa Akinori   Adachi Hiroyuki   Rino Yasushi   Masuda Munetaka   Imada Toshio  

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-05 ,pp. : 797-802

Spandidos Publications

Access to resources Recommend Favorite

Mutational analysis of the insulinlike growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients

By              

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1073-1079

Science Publishers

Access to resources Recommend Favorite

Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma

By Ekman Simon   Fröödin Jan-Erik   Harmenberg Johan   Bergman Antonina   Hedlund ÅÅsa   Dahg Pia   Alvfors Carina   Stååhl Birgitta   Bergströöm Stefan   Bergqvist Michael  

Acta Oncologica, Vol. 50, Iss. 3, 2011-04 ,pp. : 441-447

Informa Healthcare

Access to resources Recommend Favorite

Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

By        

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 931-938

Spandidos Publications

Access to resources Recommend Favorite